Sofetabart
Based on 1 Customer Validation
Sofetabart (LY-4170156 Antibody) is a humanized IgG1 antibody that specifically targets folate receptor α (FRα). Sofetabart can be used to synthesize the antibody-drug conjugate (ADC) Sofetabart mipitecan. Sofetabart is applicable to research related to advanced ovarian cancer, platinum-resistant epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer, as well as platinum-sensitive ovarian cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 98.00%
- CAS No.: 3066905-22-1
- Masse moléculaire:145.23 kDa
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Human IgG1 kappa
Human
|
FR-α |
FOLR1/FRA
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
ELISA, FACS, Functional assay
-
Loaded Sofetabart on ProA biosensor, can bind FOLR1 Protein, Human (HEK293, HY-P70296) with an affinity constant of 2.087E-08 M as determined in BLI assay.
Chemical Information
-
CAS No. 3066905-22-1
-
Masse moléculaire 145.23 kDa
-
Synonyms
LY-4170156 Antibody; MBK-103 Antibody
-
Livraison
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
Fiche technique (260 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
- Sofetabart
- 3066905-22-1
- LY-4170156 Antibody
- MBK-103 Antibody
- ADC Antibodies
- Folate Receptor (FR)
- topoisomerase-I inhibitor
- topoisomerase 1 inhibitor
- folate receptor alpha
- platinum-resistant epithelial ovarian cancer
- fallopian tube cancer
- FRα-expressing cells
- primary peritoneal cancer
- cancer cell
- advanced ovarian cancer
- platinum-sensitive ovarian cancer
- Inhibitor
- inhibitor
- inhibit